IGC IGC PHARMA INC Product Launches 8-K Filing 2024 - Interim Results for IGC-AD1 in Reducing Alzheimer's Agitation IGC Pharma Inc. announced positive interim results for IGC-AD1 in reducing Alzheimer's agitation, indicating strong therapeutic potential.Get access to all SEC 8-K filings of the IGC PHARMA INC